Search Results - Scheithauer, W

Refine Results
  1. 1
    Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.

    Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil. by Scheithauer, W., Schenk, T., Czejka, M.

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Hormone-containing, non-secreting pituitary tumors: clinically silent monohormonal pituitary adenomas.

    Hormone-containing, non-secreting pituitary tumors: clinically silent monohormonal pituitary adenomas. by Randall, R. V., Scheithauer, W., Laws, E. R.

    Published 1985
    Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    HER 2/neu protein expression in colorectal cancer

    HER 2/neu protein expression in colorectal cancer by Schuell, B, Gruenberger, T, Scheithauer, W, Zielinski, Ch, Wrba, F

    Published 2006
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours.

    Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours. by Kornek, G., Schenk, T., Raderer, M., Djavarnmad, M., Scheithauer, W.

    Published 1995
    Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.

    Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. by Scheithauer, W, Rosen, H, Kornek, G V, Sebesta, C, Depisch, D

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Human colon cancer cell lines secrete alpha TGF-like activity.

    Human colon cancer cell lines secrete alpha TGF-like activity. by Hanauske, A. R., Buchok, J., Scheithauer, W., Von Hoff, D. D.

    Published 1987
    Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    MDR1 gene expression in primary colorectal carcinomas.

    MDR1 gene expression in primary colorectal carcinomas. by Pirker, R., Wallner, J., Gsur, A., Götzl, M., Zöchbauer, S., Scheithauer, W., Depisch, D.

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer.

    123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer. by Raderer, M., Kurtaran, A., Hejna, M., Vorbeck, F., Angelberger, P., Scheithauer, W., Virgolini, I.

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

    Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy by Bernhard, J, Dietrich, D, Glimelius, B, Hess, V, Bodoky, G, Scheithauer, W, Herrmann, R

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer.

    Reinduction therapy with the same cytostatic regimen in patients with advanced colorectal cancer. by Hejna, M., Kornek, G. V., Raderer, M., Depisch, D., Brodowicz, T., Fiebiger, W. C., Scheithauer, W.

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Side effects during chemotherapy predict tumour response in advanced colorectal cancer

    Side effects during chemotherapy predict tumour response in advanced colorectal cancer by Schuell, B, Gruenberger, T, Kornek, G V, Dworan, N, Depisch, D, Lang, F, Schneeweiss, B, Scheithauer, W

    Published 2005
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer.

    Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer. by Mader, R M, Steger, G G, Rizovski, B, Djavanmard, M P, Scheithauer, W, Jakesz, R, Rainer, H

    Published 1995
    Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer.

    Scintigraphic evaluation of functional hepatic mass in patients with advanced breast cancer. by Virgolini, I., Kornek, G., Höbart, J., Li, S. R., Raolerer, M., Bergmann, H., Scheithauer, W., Pantev, T., Angelberger, P., Sinzinger, H.

    Published 1993
    Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results

    XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results by Cassidy, J, Clarke, S, Díaz-Rubio, E, Scheithauer, W, Figer, A, Wong, R, Koski, S, Rittweger, K, Gilberg, F, Saltz, L

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.

    Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor. by Kornek, G. V., Haider, K., Kwasny, W., Hejna, M., Raderer, M., Meghdadi, S., Burger, D., Schneeweiss, B., Depisch, D., Scheithauer, W.

    Published 1996
    Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.

    Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor. by Kornek, G. V., Haider, K., Kwasny, W., Lang, F., Krauss, G., Hejna, M., Raderer, M., Weinländer, G., Depisch, D., Scheithauer, W.

    Published 1998
    Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric cancer

    Effective combination chemotherapy with paclitaxel and cisplatin with or without human granulocyte colony-stimulating factor and/or erythropoietin in patients with advanced gastric... by Kornek, G V, Raderer, M, Schüll, B, Fiebiger, W, Gedlicka, C, Lenauer, A, Depisch, D, Schneeweiss, B, Lang, F, Scheithauer, W

    Published 2002
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

    Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin by Kornek, G V, Schratter-Sehn, A, Marczell, A, Depisch, D, Karner, J, Krauss, G, Haider, K, Kwasny, W, Locker, G, Scheithauer, W

    Published 2000
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma

    Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma by Scheithauer, W, Kornek, G V, Raderer, M, Hejna, M, Valencak, J, Miholic, J, Kovats, E, Lang, F, Funovics, J, Bareck, E, Depisch, D

    Published 1999
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study

    Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study by André, T, Reyes-Vidal, J M, Fartoux, L, Ross, P, Leslie, M, Rosmorduc, O, Clemens, M R, Louvet, C, Perez, N, Mehmud, F, Scheithauer, W

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: